Business Wire

‘BLUE LOCK - TOKYO EGOIST -’ kicks off on Saturday, November 22

25.11.2025 14:07:00 CET | Business Wire | Press Release

Share

In its efforts to promote nighttime tourism, the Tokyo Metropolitan Government is developing new attractions that illuminate the capital after dark. As part of this initiative, projection mapping is being presented year-round on the iconic Tokyo Metropolitan Government Building No. 1, transforming its façade into a canvas of light and sound.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251121922505/en/

©Muneyuki Kaneshiro, Yusuke Nomura, KODANSHA/BLUE LOCK Production Committee.

A brand-new production inspired by the internationally popular soccer anime“BLUE LOCK”, titled BLUE LOCK – TOKYO EGOIST –, began screening on Saturday, November 22.
On the first day of the screening, a mini-event was held at the Tokyo Metropolitan Government Plaza, where voice actors Kazuki Ura (voice of Yoichi Isagi) and Hiroshi Kamiya (voice of Jinpachi Ego) joined fans in celebrating the premiere.

Scenes from the Opening Day of the New Production BLUE LOCK – TOKYO EGOIST –

Over 6,000 Visitors on Opening Day
On Saturday, November 22: the first day of the screening, over 6,000 visitors gathered at the Tokyo Metropolitan Government Plaza, including “BLUE LOCK” fans, tourists, and families. The plaza was filled with attendees wearing the original light-up bracelets distributed in celebration of surpassing one million total viewers.
Among the visitors, some commented, ‘I was very satisfied with the powerful “BLUE LOCK” projection mapping, which offered a completely different experience from the anime. ’ ‘‘The talk session by voice actors Ura and Kamiya was also very exciting, and I enjoyed the sense of unity with the audience wearing light-up bracelets.’ Visitors enjoyed the Blue Lock visuals projected onto the massive projection surface recognized by GUINNESS WORLD RECORDS™ , as well as the special mini-event held on the opening day.

Scenes from the Opening-Day Event

Talk Event with Voice Actors Kazuki Ura and Hiroshi Kamiya
At the opening-day event, voice actors Kazuki Ura (voice of Yoichi Isagi) and Hiroshi Kamiya (voice of Jinpachi Ego) took the stage for a talk session, followed by a countdown to the premiere screening. With the two leading the call, the screening began, sending excitement through the entire venue.

Reflecting on the projection mapping, Ura commented:
"Absolutely breathtaking! The charm of Blue Lock was powerfully brought to life through powerful visuals that only projection mapping can deliver. It was a deeply moving moment to see such a cherished work projected onto the iconic Tokyo Metropolitan Government Building.”

Kamiya shared a message with fans:
"Due to the scale of the enormous visuals, it is impossible to catch all the details in just one viewing, so we hope you will watch it many times. It was a great honor for me to make my first Blue Lock-related event appearance through work at the Tokyo Metropolitan Government Building. Thank you for your continued support."

About “BLUE LOCK”
“BLUE LOCK”, is a soccer manga series written by Muneyuki Kaneshiro and illustrated by Yusuke Nomura.
Serialized in "Weekly Shonen Magazine" (Kodansha) since 2018, the series has surpassed 50 million copies in circulation worldwide.
The TV anime adaptation, which aired in 2022, gained explosive popularity not only in Japan but also overseas, captivating fans around the globe.
Set in “BLUE LOCK”, a training facility where 300 high school forwards compete to become the world’s greatest striker and revolutionize Japanese soccer, the story follows Yoichi Isagi, who grows and evolves through fierce battles with his teammates—who are also his rivals—using his own “ego” as his ultimate weapon.

©Muneyuki Kaneshiro, Yusuke Nomura, KODANSHA/BLUE LOCK Production Committee.

About the New Work “BLUE LOCK -TOKYO EGOIST- ”

TITLE “BLUE LOCK -TOKYO EGOIST- ”

HIGHLIGHTS
Numerous memorable scenes from “BLUE LOCK” appear in this special production. The Tokyo Metropolitan Government Building, officially recognized by GUINNESS WORLD RECORDS™ for its projection area of 14,000㎡, is transformed into a massive playing field. With dynamic visuals, the show powerfully portrays the fierce battles among Isagi, Nagi, Rin, and their many rivals. Experience the thrill and intensity of “BLUE LOCK” as if you were inside a real stadium!

Showtimes (November)
[Weekends & Holidays] 5:30PM / 6:30PM / 7:30PM / 9:00PM
* Other projection mapping works are also shown at times outside of the above schedule.
* Please check the event website for showtimes from December onward.

Overview of the Tokyo Metropolitan Government Building Projection Mapping: "TOKYO Night & Light"

  • Dates: Daily (except during severe weather)
  • Projection Surface: East side wall of the Tokyo Metropolitan Government Building No. 1
  • Viewing Area: Tokyo Metropolitan Government Plaza(2-8-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo)
  • Showtimes: 5:30 PM / 6:00 PM / 6:30 PM / 7:00 PM / 7:30 PM / 8:00 PM / 8:30 PM / 9:00 PM / 9:30 PM
    (These times apply in November. For updated schedules, please visit the website.)
    https://tokyoprojectionmappingproject.jp/en/
  • Organized by: Tokyo Metropolitan Government, Tokyo Projection Mapping Executive Committee
  • Additional Information: This project is committed to environmentally friendly practices, including the use of green energy. It has been officially recognized by Guinness World Records™ as “The Largest Permanent Projection Mapping Display on a Building.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20251121922505/en/

Contacts

TOKYO Night & Light PR Office
(Managed by Jishaku Inc. – Contacts: Sonobe, Hamasaki)
Email: pr@tokyo-night-and-light.jp
Phone: +81-50-8893-9652 (Sonobe)

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye